{"nct_id":"NCT03941093","title":"Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2019-05-10","start_date_type":"ACTUAL","primary_completion_date":"2024-06-11","primary_completion_date_type":"ACTUAL","completion_date":"2024-06-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["FGEN"]}